IM101-075-020 A Sequential Adaptive Phase II/III Multi-Center, Randomized, Double-Bind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus
|Effective start/end date||4/23/07 → 7/31/09|
- BRISTOL-MYERS SQUIBB COMPANY
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.